Skip to content

RAFF5 Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter

RAFF5 Proposal: Project to Improve the Quality and Safety of the Immediate and Subsequent Care of Patients Seen in the Emergency Department With Acute Atrial Fibrillation and Flutter

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05468281
Acronym
RAFF5
Enrollment
1108
Registered
2022-07-21
Start date
2022-09-01
Completion date
2023-07-30
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Flutter

Keywords

Safety, Emergency Department, Management guidelines

Brief summary

Acute atrial fibrillation (AF) and flutter (AFL) are the most common arrhythmias requiring management in the emergency department (ED). They are characterized by sudden onset of a rapid heart rate which may be irregular (AF) or regular (AFL). Our focus is on episodes of acute AF or AFL which are usually less than 48 hours in duration and are highly symptomatic, requiring rapid treatment in the ED. Management guidelines for acute AF/AFL have changed substantially in recent years with several recent revisions published by the Canadian Cardiovascular Society (CCS) and the Canadian Association of Emergency Physicians (CAEP). The 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist (CAEP Checklist) was very recently published to assist ED physicians in Canada and elsewhere manage patients who present to the ED with acute AF/AFL (Figure 1). The overall goal of this project is to improve the quality and safety of the immediate and subsequent care of patients seen in the ED with acute AF and AFL by implementing the principles of the CAEP Checklist at both The Ottawa Hospital (TOH) EDs and by working with TOH cardiologists to provide rapid cardiology follow-up processes for patients discharged from the ED. The Investigators propose a before-after cohort study using an interrupted time series design to evaluate implementation involving 720 patients at the two TOH EDs over a 24-month period.

Interventions

OTHERChecklist implementation

. Our strategies will include a) selection of local physician champions from the ED and cardiology; b) discussion of the goals of the study with the local physician groups; c) formal introduction of the CAEP Checklist to the physicians and nurses by means of presentations at staff meetings, emails, and an online video; d) development of an action plan to address local barriers to implementation; e) creation of a free smartphone application; f) regular reminders; and g) and distribution of charts of site compliance.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* include all eligible patient visits to the participating EDs during the study period regardless of how they are managed. * include stable patients aged 18 and over, * presenting with an episode of acute AF or AFL of at least 3 hours duration, * where symptoms require ED management by rhythm or rate control.

Exclusion criteria

* The study will exclude patients who have any of: 1. permanent AF; 2. deemed unstable and required immediate electrical cardioversion; or 3. primary presentation was for another condition rather than arrhythmia.

Design outcomes

Primary

MeasureTime frameDescription
Improve the quality and safety of ED management of AF and AFL14 daythe quality and safety of ED management based upon the CAEP Checklist management. best practices. The study team will use a score sheet which will identify specific managements for AF and AFL that are 1) optimal; 2) suboptimal; 3) unsafe.

Secondary

MeasureTime frameDescription
Use of cardioversion (chemical or electrical) in the EDDuration of the ED visit, approximately 4-12 hours.
use of rate control and the final heart rate at dispositionDuration of the ED visit, approximately 4-12 hours.
prescription of OAC on dischargeDuration of the ED visit, approximately 4-12 hours.Whether or not they were given an outpatient prescription for oral anticoagulants in accordance with the 2021 CAEP Checklist
consultations done in the ED by cardiologyDuration of the ED visit, approximately 4-12 hours.Whether or not the patient had an (unnecessary) consultation done in the ED by cardiology
Adverse events attributable to medical managementDuration of the ED visit, approximately 4-12 hours.adverse events including: i) conduction problems; ii) dysrhythmias; iii) hypotension requiring treatment; iv) respiratory events; f) admission to a hospital unit; and g) use of the rapid referral process.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026